The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PROs) from a phase II trial of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal and/or pulmonary involvement.
 
Sara I. Pai
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; CUE Biopharma; Fusion Pharmaceuticals; Merck; Newlink Genetics/Pharmatech; Oncolys BioPharma; Replimune; Sensei Biotherapeutics
Research Funding - Abbvie; AstraZeneca/MedImmune (Inst); CUE Biopharma; Immune Design; Merck (Inst); Tesaro; Tesaro
Travel, Accommodations, Expenses - Abbvie; AstraZeneca/MedImmune; Merck
 
Ramon Franco
No Relationships to Disclose
 
Ashok Muniappan
No Relationships to Disclose
 
Aaron D Friedman
No Relationships to Disclose
 
Jong Chul Park
No Relationships to Disclose
 
Nicholas Paul Campbell
No Relationships to Disclose
 
Seth B. Krantz
No Relationships to Disclose
 
Phillip C Song
No Relationships to Disclose
 
Cheryl Nocon
No Relationships to Disclose
 
Thomas L Carroll
No Relationships to Disclose
 
William C Faquin
No Relationships to Disclose
 
Kee-Young Shin
No Relationships to Disclose
 
Anne M. O'Neill
No Relationships to Disclose
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Blueprint Medicines; Eisai; Exelixis; Lilly; Loxo; Merck
Research Funding - Ayala Pharmaceuticals (Inst); Checkmate Pharmaceuticals (Inst); Eisai (Inst); Lilly (Inst)
Expert Testimony - Eisai